Characteristics of humoral responses to the first coronavirus disease booster vaccine and breakthrough infection in central China: a multicentre, prospective, longitudinal cohort study

Characteristics of humoral responses to the first coronavirus disease booster vaccine and breakthrough infection in central China: a multicentre, prospective, longitudinal cohort study

IntroductionThe long-term immunogenicity, adverse effects, influencing factors, and protection from booster vaccines remain unclear. Specifically, little is known regarding the humoral immunity and breakthrough infections associated with COVID-19 booster immunization. Therefore, we evaluated the imm...

Full description

Saved in:

Bibliographic Details
Main Authors:	Junhong Xu, Youhua Yuan, Guohua Chen, Bing Ma, Yin Long Zou, Baoya Wang, Wenjuan Yan, Qi Zhang, Qiong Ma, Xiaohuan Mao, Huiling Wang, Yi Li, Xiaohuan Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	breakthrough infections COVID-19 humoral immunity kinetics neutralising antibodies booster immunization
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1446751/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Breakthrough Infection After a Primary Series of COVID-19 Vaccination Induces Stronger Humoral Immunity and Equivalent Cellular Immunity to the Spike Protein Compared with Booster Shots
by: Yoshifumi Uwamino, et al.
Published: (2025-07-01)

Evaluation of humoral and cellular immune responses in healthcare workers with varying levels of SARS-CoV-2 exposure: effects of CoronaVac vaccination followed by heterologous booster
by: Shayane Martins Rodrigues Gomes, et al.
Published: (2025-05-01)

Comparable immune escape capacity between KP.2 and other SARS-CoV-2 variants in the central Chinese population after the first COVID-19 booster
by: Youhua Yuan, et al.
Published: (2025-05-01)

Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination1
by: Hongyu Wang, et al.
Published: (2023-12-01)

Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages
by: Li Guo, et al.
Published: (2023-12-01)

Longitudinal assessment of immunogenicity of inactivated COVID-19 booster immunization and breakthrough infection in blood donors: A multicenter study from 2021 to 2023
by: Ying Yan, et al.
Published: (2025-12-01)

INFLUENCE OF COLURIA GEOIDES (ROSACEAE) BAC ON HUMORAL IMMUNE RESPONCE
by: S. V. Dutova, et al.
Published: (2015-09-01)

Seaweed in the Diet as a Source of Bioactive Metabolites and a Potential Natural Immunity Booster: A Comprehensive Review
by: Amiya Kumar Mandal, et al.
Published: (2025-03-01)

Booster vaccination against the SARS-CoV-2: mechanisms and efficiency
by: S. A. Berns, et al.
Published: (2023-12-01)

Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections
by: Dana Unninayar, et al.
Published: (2025-01-01)

Monitoring humoral immune response following COVID-19 immunization and booster dose: A prospective study in tunisian healthcare workers
by: Chiraz Naffouti, et al.
Published: (2025-06-01)

Mushroom β-glucan and polyphenol formulations as natural immunity boosters and balancers: nature of the application
by: Maja Kozarski, et al.
Published: (2023-03-01)

Long-Term Persistence of Anti-Poliovirus Antibody Titers After Two-Dose Booster Immunization with Conventional Inactivated Poliovirus Vaccine Among Japanese Adults: 10-Year Observational Study
by: Shinji Fukushima, et al.
Published: (2025-04-01)

Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION Study
by: Concepció Violán, et al.
Published: (2025-07-01)

The immunostimulatory effects of fucoidan on the cellular and humoral immune response in Wistar rats
by: Rochmah Kurnijasanti, et al.
Published: (2024-08-01)

Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar
by: Remy Thomas, et al.
Published: (2025-03-01)

The effect of heat stress on humoral immnuity in broyler chickens
by: H. Hüseyin Hadimli, et al.

Evaluation of Immune Responses to Tdap Booster During Pregnancy in Women Who Received Whole Cell or Acellular Pertussis Vaccines During Childhood
by: Jesse M. Hall, et al.
Published: (2025-08-01)

State of cellular and humoral immune system in women of reproductive age with tumor-like ovary formations
by: O. S. Shapoval, et al.
Published: (2014-12-01)

Influence of Ovophospholipids on Lymphocyte Subsets and Humoral Immune Response in Mice
by: Magdalena Lis, et al.
Published: (2025-05-01)

Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice
by: Huijie Yang, et al.
Published: (2024-12-01)

Reading of human acute immune dynamics in omicron SARS-CoV-2 breakthrough infection
by: Haibo Li, et al.
Published: (2025-12-01)

BREAKTHROUGH ECONOMY: FEATURES OF FORMATION AND DEVELOPMENT IN RUSSIA
by: E. Bykovskaia, et al.
Published: (2019-11-01)

Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial
by: Aihua Yao, et al.
Published: (2025-05-01)

Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
by: Benjamin Meyer, et al.
Published: (2020-01-01)

Comparative humoral response of mRNA and inactivated vaccines against COVID-19 in healthy adults aged 60 years and older
by: Meryem Güvenir, et al.
Published: (2023-02-01)

Mediating role of psychological resilience between depression and humoral immunological biomarkers in medical staff
by: Yunyun MA, et al.
Published: (2025-04-01)

Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy
by: Sol Jin, et al.
Published: (2025-02-01)

Intranasal trivalent candidate vaccine elicits broad humoral and cellular immunity against pneumococcal pneumonia
by: Fangyu Ren, et al.
Published: (2025-06-01)

Immunogenicity evaluation of Gam-COVID-Vac (Sputnik V)
by: I. A. Kirillov, et al.
Published: (2022-12-01)

Humoral and cellular immune responses in cattle upon Clostridium chauvoei vaccination and challenge
by: Andrea Rossi, et al.
Published: (2025-05-01)

Condition of the humoral link of immune system at patients with endometrial cancer
by: A. V. Efremov, et al.
Published: (2014-08-01)

Humorous factors and main types of humor
by: Ghahreman Shiri
Published: (2024-07-01)

An examination of Wuhan City healthcare personnel afflicted with SARS-CoV-2 Omicron variants between December 15, 2022, and January 5, 2023, during the rapid Omicron outbreak in China
by: Yingyu He, et al.
Published: (2023-11-01)

Immunology and prospects of immunotherapy against malignant gliomas: humoral immunity
by: S. A. Kulyova, et al.
Published: (2021-12-01)

Systemic humoral immune status in individuals recovered from Epstein–Barr virus (EBV) infection
by: A.M. Popova, et al.
Published: (2025-04-01)

A Breakthrough Economy Management
by: I. D. Matskuluyak, et al.
Published: (2021-04-01)

Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough
by: Yichuan Yao, et al.
Published: (2025-01-01)

Varicella zoster virus mRNA vaccine candidate induced superior cellular immunity and comparable humoral and Fc-mediated immunity compared to the licensed subunit vaccine in a mouse model
by: Eun-Jeong Jang, et al.
Published: (2025-12-01)

Neutralising Neurophobia
by: Greg Lamb
Published: (2018-03-01)